Physician profile
Lynnette Allen
NPI 1922360080
$11,390.44
in general payments reported to CMS, 2019-2025
7 companies · $6,338 in 2025
The $6,338 reported for 2025 was more than what 98% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $218 · 2022: $341 · 2023: $3,341 · 2024: $1,153 · 2025: $6,338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,927 · Food and Beverage: $2,167 · Travel and Lodging: $643 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,927.00 |
| Food and Beverage | $2,167.28 |
| Travel and Lodging | $642.54 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $9,810.22 | 2021-2025 | Xeomin |
| Galderma Laboratories, L.P. | $675.00 | 2024 | |
| Biofrontera INC. | $458.58 | 2021-2025 | Ameluz, Xepi, Bf-Rhodoled |
| Janssen Biotech, INC. | $194.51 | 2023-2025 | Tremfya |
| Revance Therapeutics, INC. | $194.02 | 2024-2025 | Daxxify |
| Abbvie INC. | $42.32 | 2024 | |
| Sun Pharmaceutical Industries INC. | $15.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynnette Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.